Redox proteomics
- PMID: 22671972
- PMCID: PMC3448936
- DOI: 10.1089/ars.2012.4742
Redox proteomics
Abstract
Proteins are major targets of reactive oxygen and nitrogen species (ROS/RNS) and numerous post-translational, reversible or irreversible modifications have been characterized, which may lead to a change in the structure and/or function of the oxidized protein. Redox proteomics is an increasingly emerging branch of proteomics aimed at identifying and quantifying redox-based changes within the proteome both in redox signaling and under oxidative stress conditions. Correlation between protein oxidation and human disease is widely accepted, although elucidating cause and effect remains a challenge. Increasing biomedical data have provided compelling evidences for the involvement of perturbations in redox homeostasis in a large number of pathophysiological conditions and aging. Research toward a better understanding of the molecular mechanisms of a disease together with identification of specific targets of oxidative damage is urgently required. This is the power and potential of redox proteomics. In the last few years, combined proteomics, mass spectrometry (MS), and affinity chemistry-based methodologies have contributed in a significant way to provide a better understanding of protein oxidative modifications occurring in various biological specimens under different physiological and pathological conditions. Hence, this Forum on Redox Proteomics is timely. Original and review articles are presented on various subjects ranging from redox proteomics studies of oxidatively modified brain proteins in Alzheimer disease and animal models of Alzheimer and Parkinson disease, to potential new biomarker discovery paradigm for human disease, to chronic kidney disease, to protein nitration in aging and age-related neurodegenerative disorders, electrophile-responsive proteomes of special relevance to diseases involving mitochondrial alterations, to cardiovascular physiology and pathology.
Similar articles
-
Redox Proteomics: A Key Tool for New Insights into Protein Modification with Relevance to Disease.Antioxid Redox Signal. 2017 Mar 1;26(7):277-279. doi: 10.1089/ars.2016.6919. Epub 2017 Jan 6. Antioxid Redox Signal. 2017. PMID: 27835924 Free PMC article.
-
Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications.Antioxid Redox Signal. 2012 Dec 1;17(11):1610-55. doi: 10.1089/ars.2011.4109. Epub 2012 Jan 18. Antioxid Redox Signal. 2012. PMID: 22115501 Free PMC article. Review.
-
Redox proteomics: basic principles and future perspectives for the detection of protein oxidation in plants.J Exp Bot. 2008;59(14):3781-801. doi: 10.1093/jxb/ern252. J Exp Bot. 2008. PMID: 18977746 Review.
-
Mass spectrometry and redox proteomics: applications in disease.Mass Spectrom Rev. 2014 Jul-Aug;33(4):277-301. doi: 10.1002/mas.21374. Epub 2013 Sep 30. Mass Spectrom Rev. 2014. PMID: 24930952 Review.
-
Redox proteomics: from bench to bedside.Adv Exp Med Biol. 2014;806:301-17. doi: 10.1007/978-3-319-06068-2_13. Adv Exp Med Biol. 2014. PMID: 24952188 Review.
Cited by
-
Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification.Antioxidants (Basel). 2024 Jan 20;13(1):127. doi: 10.3390/antiox13010127. Antioxidants (Basel). 2024. PMID: 38275652 Free PMC article. Review.
-
Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer's Disease.Oxid Med Cell Longev. 2021 Apr 16;2021:7086512. doi: 10.1155/2021/7086512. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 33953837 Free PMC article. Review.
-
Redox proteomics uncovers peroxynitrite-sensitive proteins that help Escherichia coli to overcome nitrosative stress.J Biol Chem. 2013 Jul 5;288(27):19698-714. doi: 10.1074/jbc.M113.457556. Epub 2013 May 21. J Biol Chem. 2013. PMID: 23696645 Free PMC article.
-
Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.Biochim Biophys Acta. 2014 Aug;1842(8):1248-57. doi: 10.1016/j.bbadis.2013.09.015. Epub 2013 Oct 9. Biochim Biophys Acta. 2014. PMID: 24120836 Free PMC article. Review.
-
A decade of proteomics studies of glaucomatous neurodegeneration.Proteomics Clin Appl. 2014 Apr;8(3-4):154-67. doi: 10.1002/prca.201300115. Epub 2014 Feb 16. Proteomics Clin Appl. 2014. PMID: 24415558 Free PMC article. Review.
References
-
- Butterfield DA. Poon HF. St. Clair D. Keller JN. Pierce WM. Klein JB. Markesbery WR. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis. 2006;22:223–232. - PubMed
-
- Butterfield DA. Sultana R. Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis. 2007;12:61–72. - PubMed
-
- Dalle-Donne I. Rossi R. Colombo G. Giustarini D. Milzani A. Protein S-glutathionylation: a regulatory device from bacteria to humans. Trends Biochem Sci. 2009;34:85–96. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical